AIS Healthcare Acquires Hunt Valley PharmaLAB

Jabil Acquires Pharmaceutics International (Pii)

February 6, 2025

Pharmaceuticals

Jabil has acquired Pharmaceutics International (Pii), a Hunt Valley, Maryland-based contract development and manufacturing organization (CDMO) that provides aseptic filling, lyophilization and oral solid dose manufacturing. The all-cash transaction represents an exit for a consortium led by Signet Healthcare Partners, Athyrium Capital Management, Hildred Capital and Pharmascience Inc., and brings Pii’s ~300+ employees and four-site campus into Jabil’s Pharmaceutical Solutions offering to expand its drug development and manufacturing capabilities.

Revelation Pharma (Osceola Capital) Acquires Harrow Health's Non‑Ophthalmic Compounding Business

October 12, 2022

Healthcare Services

Osceola Capital-backed Revelation Pharma has acquired the non-ophthalmic compounding business of NASDAQ-listed Harrow Health as the twelfth add-on to the Revelation platform. The deal lets Revelation expand its national footprint of 503A and 503B compounding pharmacies while Harrow focuses solely on ophthalmic medications.

Vision Innovation Partners Acquires Ophthalmic Associates

September 16, 2021

Healthcare Services

Vision Innovation Partners, a Mid-Atlantic eye care platform backed by Centre Partners, has acquired Ophthalmic Associates, a provider of integrated eye care services with five locations and an ambulatory surgery center in Western Pennsylvania. The add-on expands Vision Innovation Partners' footprint in Pennsylvania and strengthens its network of ophthalmology practices and surgery centers in the Mid-Atlantic region.

Vision Innovation Partners Acquires Advanced Eye Care (Bel Air, MD)

December 30, 2021

Healthcare Services

Vision Innovation Partners, a Centre Partners‑backed eye care platform, has acquired Advanced Eye Care, a comprehensive ophthalmology practice with an onsite med spa in Bel Air, Maryland. The add-on expands Vision Innovation Partners' Mid‑Atlantic footprint and enhances its network of practices and surgery centers.

Altasciences Acquires Alliance Contract Pharma

February 27, 2020

Pharmaceuticals

Altasciences, a mid-size contract research organization based in Laval, Quebec, has acquired Alliance Contract Pharma to add small-molecule contract manufacturing and analytical services, including commercial manufacturing, GMP warehouse storage, and clinical supply distribution. The acquisition expands Altasciences' integrated early‑phase drug development offering by adding manufacturing and analytical capabilities to its preclinical, clinical, and bioanalytical services.

Aditxt Inc. Signs Share Exchange Agreement to Acquire AiPharma Global Holdings LLC

December 28, 2021

Biotechnology

Aditxt Inc. (Nasdaq: ADTX) signed a share exchange agreement to acquire AiPharma Global Holdings LLC, a wholly owned subsidiary of AiPharma Group Ltd., in a two-step transaction that initially transfers a 9.5% interest followed by the remaining 90.5% subject to closing conditions and shareholder/Nasdaq approvals. The deal would give Aditxt commercial presence in infectious disease therapeutics and access to AiPharma's rights to Avigan (favipiravir) and related antiviral assets and distribution networks.